Report Categories
View AllRecent Articles
View All
Brinker International EAT Q1 2026 Earnings Surprise EPS 290 Up Significant
Blaize Wts BZAIW Stock Down 2117 Support Test at 033 20260515
Elon Musk Vows to Appeal After Jury Rules Against Him in OpenAI Legal Battle
Cerebras IPO Prices at 185 Surpassing ExpectationsA Key Test for AI Infrastructure Demand
Inflation Rate Projected to Hit 6 in Second Quarter Top Economic Forecasters Say
Indian Markets Edge Higher on RBI Support But Weak Momentum Caps Gains
Prediction Market Investments Continue Despite Regulatory Uncertainty Earnings Calls Suggest
Intel Corporation INTC Trading Volume Analysis Leading US Stocks in Early 2026
Market Morning Briefing SpaceX IPO Buzz Nvidia Results and Bezos on AI Hype
Scope for meaningful rate cuts going ahead Neelkanth Mishra
BioHarvest Sciences Q1 2025 Earnings EPS Misses Estimates Stock Gains Amid Operational Progress
CNA Q1 2026 Earnings Earnings Miss Expectations as EPS Falls 34 Below Consensus
CIA Q1 2026 Earnings EPS Misses Consensus by Over 40
DHR Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency
INFU Q1 2026 Earnings Strong EPS Beat Offsets Cautious Market Sentiment
FLYX Q1 2026 Earnings EPS Surprises to the Upside Stock Climbs 234
Autolus Therapeutics AUTL Advances 394 as Momentum Builds Toward Key Resistance
MI Homes MHO Holds Steady Near Support as Homebuilder Sector Shows Mixed Signals
Nuveen Select Tax Free Income Portfolio NXP Holds Near Resistance Amid Modest Gains
VisionSys AI VSA Surges Over 27 on Heavy Volume Key Levels to Watch
Casella Waste Systems CWST Faces Resistance Near 90 as Shares Pull Back Slightly
External Links
US Q1 GDP Growth Revised Down to 16 Annual Rate
UPS Q1 2026 Earnings EPS Beat Lifts Stock Amid Mixed Operating Environment
Flushing Financial Stock Slips as Resistance Holds Firm
Loar Holdings LOAR Edges Lower Amid Consolidation Key Levels to Watch
IGC Pharma Holds Steady at 029 as Stock Consolidates Near Key Levels
ProFrac Holding ACDC Slips Lower as Pressure Persists Near Support Levels
XBP Global Holdings XBP Gains 3 Testing Key Resistance at 281
Ernexa Therapeutics ERNA Surges 431 Key Levels and Technical Outlook
Nasus Pharma NSRX Gains 389 as Biotech Investors Eye Key Resistance
PDF Solutions Surges 527 as Shares Test Key Resistance Levels